Crossmark Global Holdings, Inc. Novo Nordisk A S Transaction History

Crossmark Global Holdings, Inc.

  • $5.49 Billion
  • Q4 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 51,096 shares of NVO stock, worth $4.49 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
51,096
Previous 52,596 2.85%
Holding current value
$4.49 Million
Previous $6.26 Million 29.83%
% of portfolio
0.08%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$85.0 - $120.04 $127,500 - $180,060
-1,500 Reduced 2.85%
51,096 $4.4 Million
Q3 2024

Nov 04, 2024
BUY
$119.07 - $145.42 $1.49 Million - $1.82 Million
12,539 Added 31.3%
52,596 $6.26 Million
Q2 2024

Jul 29, 2024
BUY
$122.71 - $146.91 $178,543 - $213,754
1,455 Added 3.77%
40,057 $5.72 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $199,012 - $264,908
-1,949 Reduced 4.81%
38,602 $4.96 Million
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $42,748 - $51,354
487 Added 1.22%
40,551 $4.2 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $1.82 Million - $3.99 Million
19,990 Added 99.58%
40,064 $3.73 Million
Q2 2023

Jul 31, 2023
BUY
$155.98 - $172.65 $69,567 - $77,001
446 Added 2.27%
20,074 $3.17 Million
Q1 2023

May 12, 2023
BUY
$132.34 - $159.14 $15,086 - $18,141
114 Added 0.58%
19,628 $3.12 Million
Q4 2022

Jan 19, 2023
SELL
$102.55 - $135.33 $18,151 - $23,953
-177 Reduced 0.9%
19,514 $2.64 Million
Q3 2022

Nov 01, 2022
BUY
$95.28 - $116.93 $248,776 - $305,304
2,611 Added 15.29%
19,691 $1.96 Million
Q2 2022

Jul 29, 2022
SELL
$103.24 - $121.81 $78,462 - $92,575
-760 Reduced 4.26%
17,080 $1.9 Million
Q1 2022

May 11, 2022
BUY
$93.1 - $112.54 $165,718 - $200,321
1,780 Added 11.08%
17,840 $1.98 Million
Q4 2021

Jan 10, 2022
BUY
$95.88 - $117.08 $24,449 - $29,855
255 Added 1.61%
16,060 $1.8 Million
Q3 2021

Oct 21, 2021
BUY
$84.42 - $106.62 $108,057 - $136,473
1,280 Added 8.81%
15,805 $1.52 Million
Q3 2021

Oct 13, 2021
SELL
$84.42 - $106.62 $98,771 - $124,745
-1,170 Reduced 7.45%
14,525 $458,000
Q2 2021

Jul 21, 2021
SELL
$67.66 - $84.76 $125,171 - $156,806
-1,850 Reduced 10.54%
15,695 $1.32 Million
Q1 2021

Apr 15, 2021
SELL
$67.06 - $75.82 $2.23 Million - $2.52 Million
-33,245 Reduced 65.46%
17,545 $1.18 Million
Q4 2020

Jan 14, 2021
SELL
$63.89 - $73.8 $249,362 - $288,041
-3,903 Reduced 7.14%
50,790 $3.55 Million
Q3 2020

Oct 08, 2020
BUY
$63.69 - $70.22 $2,866 - $3,159
45 Added 0.08%
54,693 $3.8 Million
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $1.67 Million - $1.94 Million
28,545 Added 109.36%
54,648 $3.58 Million
Q1 2020

Apr 28, 2020
SELL
$49.46 - $64.78 $53,713 - $70,351
-1,086 Reduced 3.99%
26,103 $1.57 Million
Q4 2019

Feb 06, 2020
SELL
$49.86 - $58.26 $1.7 Million - $1.99 Million
-34,136 Reduced 55.66%
27,189 $1.57 Million
Q3 2019

Oct 09, 2019
SELL
$47.54 - $53.43 $935,777 - $1.05 Million
-19,684 Reduced 24.3%
61,325 $3.17 Million
Q2 2019

Jul 09, 2019
BUY
$46.79 - $52.47 $70,606 - $79,177
1,509 Added 1.9%
81,009 $4.14 Million
Q1 2019

May 02, 2019
BUY
$46.36 - $52.63 $181,174 - $205,678
3,908 Added 5.17%
79,500 $4.16 Million
Q4 2018

Jan 31, 2019
SELL
$41.54 - $47.25 $20,770 - $23,625
-500 Reduced 0.66%
75,592 $3.48 Million
Q3 2018

Nov 08, 2018
BUY
$46.76 - $51.24 $892,321 - $977,812
19,083 Added 33.47%
76,092 $3.59 Million
Q2 2018

Jul 31, 2018
SELL
$44.29 - $50.42 $1.75 Million - $2 Million
-39,587 Reduced 40.98%
57,009 $2.63 Million
Q1 2018

Apr 16, 2018
SELL
$48.49 - $58.14 $830,633 - $995,938
-17,130 Reduced 15.06%
96,596 $4.76 Million
Q4 2017

Feb 05, 2018
BUY
$47.53 - $53.73 $1.28 Million - $1.45 Million
26,961 Added 31.07%
113,726 $6.1 Million
Q3 2016

Oct 25, 2017
BUY
N/A
86,765
86,765 $4.18 Million

Others Institutions Holding NVO

# of Institutions
1,904
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email